JPWO2021112235A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021112235A5 JPWO2021112235A5 JP2021562750A JP2021562750A JPWO2021112235A5 JP WO2021112235 A5 JPWO2021112235 A5 JP WO2021112235A5 JP 2021562750 A JP2021562750 A JP 2021562750A JP 2021562750 A JP2021562750 A JP 2021562750A JP WO2021112235 A5 JPWO2021112235 A5 JP WO2021112235A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- adrenomedullin
- amino acid
- acid sequence
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 38
- ULCUCJFASIJEOE-NPECTJMMSA-N adrenomedullin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H]1C(N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)[C@@H](C)O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 ULCUCJFASIJEOE-NPECTJMMSA-N 0.000 claims 24
- 102000004379 Adrenomedullin Human genes 0.000 claims 19
- 101800004616 Adrenomedullin Proteins 0.000 claims 19
- 125000003275 alpha amino acid group Chemical group 0.000 claims 19
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 14
- 239000003814 drug Substances 0.000 claims 5
- 230000000694 effects Effects 0.000 claims 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000012453 solvate Substances 0.000 claims 4
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims 3
- 125000005647 linker group Chemical group 0.000 claims 3
- 230000004048 modification Effects 0.000 claims 3
- 238000012986 modification Methods 0.000 claims 3
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- 125000000539 amino acid group Chemical group 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims 2
- 125000003827 glycol group Chemical group 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- 108060003951 Immunoglobulin Proteins 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 102000018358 immunoglobulin Human genes 0.000 claims 1
- 208000017169 kidney disease Diseases 0.000 claims 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019220002 | 2019-12-05 | ||
| PCT/JP2020/045294 WO2021112235A1 (ja) | 2019-12-05 | 2020-12-04 | C3腎症を予防又は治療するための医薬、医薬組成物及び補体C3b分解促進剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2021112235A1 JPWO2021112235A1 (https=) | 2021-06-10 |
| JPWO2021112235A5 true JPWO2021112235A5 (https=) | 2022-08-01 |
Family
ID=76221743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562750A Pending JPWO2021112235A1 (https=) | 2019-12-05 | 2020-12-04 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2021112235A1 (https=) |
| WO (1) | WO2021112235A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106164088B (zh) * | 2014-03-20 | 2021-11-23 | 国立大学法人宫崎大学 | 长效肾上腺髓质素衍生物 |
| SG10202111663PA (en) * | 2017-02-27 | 2021-12-30 | Regeneron Pharma | Humanized model of kidney and liver disorders |
-
2020
- 2020-12-04 WO PCT/JP2020/045294 patent/WO2021112235A1/ja not_active Ceased
- 2020-12-04 JP JP2021562750A patent/JPWO2021112235A1/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001273388B2 (en) | "Pseudo"-native chemical ligation | |
| EP1263471B1 (en) | Antimicrobial compounds and formulations | |
| JP4067058B2 (ja) | Peg化hgf | |
| US20080318849A1 (en) | Kahalalide F and Related Compounds | |
| JPWO1996028475A1 (ja) | Peg化hgf | |
| CA2192787A1 (en) | Pth or pthrp antagonists | |
| MX2011005363A (es) | Peptidos para inhibicion del factor alfa de necrosis tumoral y usos de los mismos. | |
| JPWO2021112235A5 (https=) | ||
| JP3274225B2 (ja) | アミノ酸誘導体及びその用途 | |
| JPH03120297A (ja) | 抗凝固ペプチド | |
| CN1041157A (zh) | 肽醇抗血凝剂 | |
| CN1119650A (zh) | 具有胃肠道运动刺激活性的胃动素样多肽 | |
| AR134636A1 (es) | Compuestos peptídicos híbridos que tienen un residuo de lisina modificado | |
| WO2007095659A1 (de) | Peptide und peptid-derivate, herstellun derselben sowie deren verwendung zur herstellung eines therapeutisch und/oder präventiv wirkenden arzneimittels | |
| JPH05508850A (ja) | 抗凝固ペプチド | |
| JPWO2021112220A5 (https=) | ||
| JPH0769915A (ja) | ウィルス感染・増殖抑制剤 | |
| JP3190765B2 (ja) | ペプチド誘導体及びその用途 | |
| CA2362525A1 (en) | Cyclic peptides and aids vaccines | |
| TW202511281A (zh) | 抗病毒多肽類似物 | |
| KR20250094725A (ko) | Ccr2 억제제 및 사용 방법 | |
| WO2025043696A1 (zh) | 抗病毒多肽类似物 | |
| US5502164A (en) | Peptide compounds having therapeutic activity | |
| JP4188897B2 (ja) | ウィルス感染・増殖抑制剤 | |
| HK40100630A (zh) | 抗病毒多肽类似物 |